Skip to main content

Creating great expectations

Just passing this along as the awards, as well as the award's namesake, might be of interest to readers.

7/5/2008
FOR IMMEDIATE RELEASE
CONTACT:Christopher Danielsen

Public Relations
National Federation of the Blind(410) 659-9314, extension 2330(410) 262-1281(Cell)cdanielsen@nfb.org

National Federation of the Blind Awards $100,000
First-ever Dr. Jacob Bolotin Awards Presented at 2008 Convention


Baltimore, Maryland (July 7, 2008): The National Federation of the Blind presented $100,000 in cash awards to individuals and organizations that have made outstanding contributions toward achieving the full integration of the blind into society on a basis of equality. The first-ever Dr. Jacob Bolotin Awards honored ten innovators in the blindness field at the National Federation of the Blind’s annual convention in Dallas on Friday, July 4.

Awards in the amount of $30,000 were given to Dr. George Kerscher and collectively, BLIND, Inc., the Colorado Center for the Blind, and the Louisiana Center for the Blind. Deborah Kent Stein and Adaptap received $10,000 cash awards. Noreen Grice, Bookshare.org, Linda Miller, and Robert Leslie Newman were each awarded $5,000.

Dr. Jacob Bolotin–the namesake of the award program–was a blind physician who lived and practiced in Chicago in the early twentieth century. He was widely known and respected in Chicago and throughout the Midwest during his career, which spanned the period from 1912 until his untimely death at the age of thirty-six in 1924.

He was particularly recognized for his expertise on diseases of the heart and lungs. Bolotin used his many public speaking engagements to advocate for the employment of the blind and their full integration into society.

Marc Maurer, President of the National Federation of the Blind, said: “Dr. Jacob Bolotin was a pioneer who overcame low expectations and discrimination to become a renowned member of the medical profession without the benefit of the support services and civil rights protections available to blind people today.

The National Federation of the Blind is proud to honor the memory and spirit of Dr. Bolotin by recognizing and financially supporting those who are doing exceptional work to help achieve the shared dream of Dr. Bolotin and the National Federation of the Blind–a society where the blind are treated as productive, independent, and equal citizens.”The Jacob Bolotin Award Program is funded through the generosity of Dr. Bolotin’s nephew and niece, Alfred and Rosalind Perlman.

The late Mrs. Perlman established the Alfred and Rosalind Perlman Trust to endow the award. Income from the trust is distributed to the National Federation of the Blind and the Santa Barbara Foundation for the purpose of administering the Dr. Jacob Bolotin Award Program. Mrs. Perlman also wrote The Blind Doctor: The Jacob Bolotin Story. The book was published by Blue Point Books and is available through the National Federation of the Blind. A portion of the proceeds from book sales will also benefit the award program. For more information about the Jacob Bolotin Award Program, including more information about this year’s winners, as well as eligibility criteria and application procedures, visit
www.nfb.org.

###

About the National Federation of the BlindWith more than fifty thousand members, the National Federation of the Blind is the largest and most influential membership organization of blind people in the United States. The NFB improves blind people’s lives through advocacy, education, research, technology, and programs encouraging independence and self-confidence. It is the leading force in the blindness field today and the voice of the nation's blind. In January 2004 the NFB opened the National Federation of the Blind Jernigan Institute, the first research and training center in the United States for the blind led by the blind.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria